Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans for New‐Onset Polyarticular Juvenile Idiopathic Arthritis

Publisher： John Wiley & Sons Inc

E-ISSN： 2151-4658|66|7|1063-1072

ISSN： 2151-464x

Source： ARTHRITIS CARE AND RESEARCH, Vol.66, Iss.7, 2014-07, pp. : 1063-1072

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-term experience with biologic therapies for the treatment of polyarticular juvenile idiopathic arthritis

By Klein Ariane   Horneff Gerd  

Clinical Investigation, Vol. 3, Iss. 5, 2013-05 ,pp. : 493-504

Future Science

Access to resources Recommend Favorite

Radiological improvement by tocilizumab in polyarticular juvenile idiopathic arthritis

By  

PEDIATRICS INTERNATIONAL, Vol. 57, Iss. 2, 2015-04 ,pp. : 307-310

John Wiley & Sons Inc

Access to resources Recommend Favorite

Novel Method to Collect Medication Adverse Events in Juvenile Arthritis: Results From the Childhood Arthritis and Rheumatology Research Alliance Enhanced Drug Safety Surveillance Project

By  

ARTHRITIS CARE AND RESEARCH, Vol. 67, Iss. 4, 2015-04 ,pp. : 529-537

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effectiveness of First‐Line Treatment With Recombinant Interleukin‐1 Receptor Antagonist in Steroid‐Naive Patients With New‐Onset Systemic Juvenile Idiopathic Arthritis: Results of a Prospective Cohort Study

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 66, Iss. 4, 2014-04 ,pp. : 1034-1043

John Wiley & Sons Inc

Access to resources Recommend Favorite

Epidemiology and Treatment of New‐Onset and Established Rheumatoid Arthritis in an Insured US Population

By  

ARTHRITIS CARE AND RESEARCH, Vol. 67, Iss. 12, 2015-12 ,pp. : 1646-1655

John Wiley & Sons Inc

Access to resources Recommend Favorite